EP1180240A4 - Process for utilizing epitopes recognized by natural antibodies - Google Patents

Process for utilizing epitopes recognized by natural antibodies

Info

Publication number
EP1180240A4
EP1180240A4 EP00930168A EP00930168A EP1180240A4 EP 1180240 A4 EP1180240 A4 EP 1180240A4 EP 00930168 A EP00930168 A EP 00930168A EP 00930168 A EP00930168 A EP 00930168A EP 1180240 A4 EP1180240 A4 EP 1180240A4
Authority
EP
European Patent Office
Prior art keywords
utilizing
epitopes recognized
natural antibodies
antibodies
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00930168A
Other languages
German (de)
French (fr)
Other versions
EP1180240A1 (en
Inventor
Jon A Wolff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrowhead Madison Inc
Original Assignee
Mirus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mirus Corp filed Critical Mirus Corp
Publication of EP1180240A1 publication Critical patent/EP1180240A1/en
Publication of EP1180240A4 publication Critical patent/EP1180240A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00930168A 1999-04-27 2000-04-27 Process for utilizing epitopes recognized by natural antibodies Withdrawn EP1180240A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13115199P 1999-04-27 1999-04-27
US131151P 1999-04-27
US13943199P 1999-06-07 1999-06-07
US139431P 1999-06-07
PCT/US2000/011270 WO2000065350A1 (en) 1999-04-27 2000-04-27 Process for utilizing epitopes recognized by natural antibodies

Publications (2)

Publication Number Publication Date
EP1180240A1 EP1180240A1 (en) 2002-02-20
EP1180240A4 true EP1180240A4 (en) 2004-10-27

Family

ID=26829186

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00930168A Withdrawn EP1180240A4 (en) 1999-04-27 2000-04-27 Process for utilizing epitopes recognized by natural antibodies

Country Status (2)

Country Link
EP (1) EP1180240A4 (en)
WO (1) WO2000065350A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811093A (en) * 1994-04-05 1998-09-22 Exponential Biotherapies, Inc. Bacteriophage genotypically modified to delay inactivations by the host defense system
US5622699A (en) * 1995-09-11 1997-04-22 La Jolla Cancer Research Foundation Method of identifying molecules that home to a selected organ in vivo

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CORTESE R ET AL: "EPITOPE DISCOVERY USING PEPTIDE LIBRARIES DISPLAYED ON PHAGE", TRENDS IN BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, GB, vol. 12, 1 July 1994 (1994-07-01), pages 262 - 267, XP000652420, ISSN: 0167-7799 *
CORTESE R ET AL: "Identification of biologically active peptides using libraries displayed on phage", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 6, no. 1, 1995, pages 73 - 80, XP002107140, ISSN: 0958-1669 *
FOLGORI A ET AL: "A GENERAL STRATEGY TO IDENTIFY MIMOTOPES OF PATHOLOGICAL ANTIGENS USING ONLY RANDOM PEPTIDE LIBRARIES AND HUMAN SERA", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 13, no. 9, 1 May 1994 (1994-05-01), pages 2236 - 2243, XP000441903, ISSN: 0261-4189 *
GEVORKIAN G ET AL: "RAPID COMMUNICATION IDENTIFICATION OF AUTOIMMUNE THROMBOCYTOPENIC PURPURA-RELATED EPITOPES USING PHAGE-DISPLAY PEPTIDE LIBRARY", CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, SAN DIEGO, CA, US, vol. 86, no. 3, 1998, pages 305 - 309, XP000915569, ISSN: 0090-1229 *
MENNUNI C ET AL: "Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 268, no. 3, 9 May 1997 (1997-05-09), pages 599 - 606, XP004459778, ISSN: 0022-2836 *
PUNTORIETO G ET AL: "Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 17, no. 13, 1 July 1998 (1998-07-01), pages 3521 - 3533, XP002111268, ISSN: 0261-4189 *
See also references of WO0065350A1 *

Also Published As

Publication number Publication date
EP1180240A1 (en) 2002-02-20
WO2000065350A1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
IL156030A0 (en) Humanized antibodies
AU1174702A (en) Humanized anti-lt-beta-r antibodies
HK1203521A1 (en) Antibodies to nsulin-like growth factor receptor
EP1467756A4 (en) Methods for using anti-muc18 antibodies
MXPA03008031A (en) Expression technology for proteins containing a hybrid isotype antibody moiety.
EP1073464A4 (en) Monoclonal antibodies with reduced immunogenicity
EP1229125A4 (en) Process for producing polypeptide
IL166244A0 (en) Super humanized antibodies
EP1514928A4 (en) Method for producing antibodies
EP1169352A4 (en) Erythropoietin receptor antibodies
GB9911569D0 (en) Antibodies
HUP0400030A3 (en) Antibodies specific for cd44v6
GB2387599B (en) Methods for producing antibodies
AU4363401A (en) Novel process for preparing (+)-cis-sertraline
HUP0104405A3 (en) Process for preparing imidachlopid
EP1243657A4 (en) Process for producing glycine
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
EP1180240A4 (en) Process for utilizing epitopes recognized by natural antibodies
AU2001249546A1 (en) Methods for treating disease with antibodies to cxcr3
EP1534827A4 (en) Method for generating monoclonal antibodies
GB0003359D0 (en) Monoclonal antibodies
GB0008160D0 (en) Monoclonal antibodies
IL157966A0 (en) Antibodies specific for cd44v6
GB9923153D0 (en) Chimeric antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20040913

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/68 A

17Q First examination report despatched

Effective date: 20050428

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050906